Sarcomas Flashcards

1
Q

What is a sarcoma?
Subtypes?

A
  • a malignant cancer that arises from transformed cells of mesenchymal origin
  • Mesenchyme – cells of connective / structural tissues

Subtypes vary by cell of origin
* Bone - osteosarcoma
* Connective tissue - soft tissue sarcoma, fibrosarcoma, myxosarcoma
* Peripheral nerves - peripheral nerve sheath tumour
* Blood vessels - haemangiosarcoma
* Muscle – rhabdomyosarcoma (striated muscle rare), leiomyosarcoma (smooth muscle - uncommon)
* Fat – infiltrative lipoma, liposarcoma
* Cartilage - chondrosarcoma, synovial cell sarcoma
* (Lymphatic and haematopoetic cells – many of these tumours are considered separately – based on behaviour)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is general behaviour of sarcomas?

A
  • Locally invasive
    *Metastatic risk varies with tumour type (osteosarc, haemangiosarc = v high) + Grade
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How would you assess sarcomas?

A
  • Clinical examination
  • Diagnosis = FNA + cytology, Biopsy and histology, +/- IHC
  • Staging - is there evidence of metastasis ?
  • Aspiration of local lymph nodes
  • Imaging dependent upon tumour type
  • Sample other abnormalities identified on examination
  • Co-morbidities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How would you perform primary tumour imaging?

A
  • Radiographs are relatively insensitive
    – >60% of mineral content of bone must be lost for lysis to become apparent
    – All soft tissues except fat look the same
  • CT better
    – Better appreciation of osteolysis or new bone production
    – Many more shades of grey
    – Surgical planning
    – Radiation planning
  • MRI – Excellent for surgical planning esp trunk/body wall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is most likely location of mets for sarcoma?

A
  • Lungs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are soft tissue sarcomas?

A
  • Tumours of mesenchymal origin
  • Account for 9 -15% of all canine tumours
  • Middle to large breeds may be predisposed
  • Median age 8 -11 years
  • Some breed predilections – Fibrosarcomas in Retrievers
  • Younger animals in predisposed breeds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is surgical Tx?

A
  • Tumours = grow along path of least resistance, often have a pseudocapsule (do not try to ‘shell out’)
  • Complete excision important to outcome
  • Ideal surgical margins = 3 cm lateral and 1 fascial plane
    beyond the extent of tumour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How are margins of excision assessed?

A
  • Most common = CARDINAL = 3 cross sections
  • Bread loafing (cut like you would a loaf)
  • Shaved margins - expensive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is incomplete excision?

A
  • Residual tumour tissue still in animal = tumour likely to recur
  • Tumour cells within <3mm of tissue edge
  • Probability of recurrence depend on tumour type + grade
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What can be done if incomplete excision + microscopic residual disease?

A
  • Further wide surgical excision
  • Adjuvant radiation therapy
  • Active monitoring - high risk (only considered when chance of recurrence is low)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are prognostic factors for post tumour removal?

A
  • Successful surgery = MST >4years

Progonstic factors =
* Tumour grade and mitotic rate
* Tumour size
* Tumour location
* Achieving local control of the tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What should be done with non-resectable tumours?

A
  • Refer to specialist?
  • Reduce tumour to microscopic disease - followed by RT / chemotherapy
  • Primary RT = less effective
  • Anti-metastatic treatment - for high grade soft tissue sarcomas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are feline injection site sarcomas?

A
  • Tumours develop at sites where cats typically get injections
  • Research has shown location of tumours change with vaccine practices
  • Development associated with certain vaccines (Rabies / FeLV) but can be seen in cats who have never had these
  • Histologically =
  • Malignant fibroblasts
  • Inflammation – often high lymphocyte component
  • Macrophages taking up foreign material thought to be adjuvant / carrier
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How would you assess a feline injection site sarcoma?

A
  • Examination – Usually firm cutaneous or subcutaneous mass
  • 3-2-1 rule for investigation = USE FOR DIAGNOSIS
    – Any mass present for 3 months or longer
    – Any mass greater than 2cm diameter
    – Any mass that continues to increase in size 1 month after injection
  • incisional Biopsy
  • Advanced imaging - assess size + margins (highly invasive)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why would you not perform excisional biopsy?

A
  • Almost guarantee treatment failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How would you treat FISS?

A
  • Surgery - 5cm + lateral surgical margins + 2 fascial planes deep
    – This can involve removal of spinous processes of vertebrae
    – Recurrence rates = 47% with dirty margins, 19 % with complete excision
  • First surgery is best chance of a good outcome
17
Q

What is adjuvant Tx, When would you use it?

A
  • Doxorubicin based chemotherapy +/or radiation therapy
  • For non-resectable tumours - pre-op RT +/or chemotherapy
  • For incomplete resections / marginal resections
18
Q

How can you prevent FISS?

A
  • Injections to be given in sites amenable to wide surgical excision e.g. limb or tail
  • Reduce inflammatory reactions at injection sites – avoiding irritating substances where possible
  • Do not over-vaccinate
19
Q

What are bone tumours? What animals are predisposed?

A
  • 85 % of skeletal tumours are osteosarcoma
  • Middle age and older dogs
  • Small peak in younger dogs
  • Typically large breeds =
  • Appendicular skeleton – metaphysis of long bones
  • Front limbs 2:1 hind limbs
  • Small breeds <15 kg contribute only 5 %
  • 60% OSA in axial skeleton
20
Q

What are clinical signs + Dx of bone tumours?

A
  • Pain and lameness = Sudden or progressive onset, Localisable to a single bone
  • Swelling
  • Radiographic changes – do not differentiate tumour type
  • Bone lysis
  • Soft tissue swelling
  • New bone – palisades perpendicular to bone – sunburst
  • Periosteal elevation – Codman’s triangle
  • Long zone of transition
  • Does not cross joint
  • Cytology or histology required to confirm diagnosis
21
Q

What are Ddx for bone tumours?

A
  • Beyond OSA - other differentials include:
  • Chondrosarcoma - low metastatic risk
  • Histiocytic sarcoma - metastatic risk depends upon location
  • Other primaries include fibrosarcoma, haemangiosarcoma
  • Other differentials =
  • Myeloma / lymphoma (round cell tumour)
  • Fungal osteomyelitis
  • Metastatic tumours (carcinoma)
  • Benign tumours / cysts
22
Q

How are bone tumours treated?

A

*Aims = Prevention of pain, Delaying development of metastases and extending life

*Amputation =
- Most dogs tolerate amputation very well - Even large dogs and those with mild to moderate orthopaedic problems
- Patients pain free around 1 week after amputation
- Complete ambulatory adaptation takes around 1 month

23
Q

How can you reduce pain with bone tumours?

A
  • AMPUTATION should eliminate pain
  • Analgesics - Use layered, multi-modal approach
  • Opoids, NSAIDS, paracetamol, amantidine
  • Slow bone destruction - Bisphosphonates e.g. pamidronate q 4 weeks
  • Reduce sensation - Radiation therapy
  • Ongoing and increasing risk of pathological fracture
  • Bone stabilisation and fixation by limb sparing surgery
  • Aim is to retain limb function
  • High rate of infection and implant failure

** PATIENT UNLIKELY TO BE PAIN FREE **

24
Q

What are osteosarcoma prognostic factors?

A
  • Location =
  • appendicular - humerus, rib, vertebral + pelvis (poorer prognosis)
  • axial - skull OSA = lower metastatic rate, maxilla/ calvarium (worse px)
  • Presence of metastatic disease
  • Total alkaline phosphatase
25
Q

What should be done for Feline osteosarcoma?

A
  • AMPUTATION
  • Much lower metastatic potential
  • Amp may cure!
26
Q

What are haemangiosarcomas?

A
  • Tumours of blood vessel walls - most common in spleen
  • highly invasive + metastatic
27
Q

CS + Dx of haemangiosarc?

A
  • Clinical signs usually associated with bleeding
  • Shock, collapse, haemoabdomen or pericardial effusion
  • Intramuscular – bruising in the dependent part of the limb
  • Pericardial effusion if right auricular appendage
  • Clinical pathology changes reflect bleeding and altered coagulation
  • Anaemia and sometimes schistocytosis
  • In early stages of bleeding - effusion and reduced TP precede measurable anaemia
  • Low platelet count
  • Prolonged coagulation tests and DIC
  • Diagnosis usually requires histology
  • Staging = imaging / cytology
28
Q

What are poor prognostic factors for haemangiosarcomas?

A
  • Tumour rupture and bleeding into the abdomen
  • but diagnosis often not known at this point
  • Other types of splenic tumour will also rupture
  • Invasive tumours in other sites
29
Q

How are primary lesions of haemagiosarc treated?

A
  • Surgery =
  • Splenectomy
  • Beware of ventricular arrythmias after splenectomy
  • Compartmental or wide excision in other sites
  • Survival after splenectomy depends on stage
  • Short if gross metastases already
  • In non-visceral sites, moderately responsive to radiation
  • Useful for muscular or dermal tumours
30
Q

How is metastatic disease treated?

A
  • Survival with metastasis typically 4 – 6 weeks for splenic
  • Chemotherapy more useful if no gross metastasis
  • Systemic chemotherapy with anthracycline based protocol
  • 4 – 6 treatments at 3 weekly intervals
  • For splenic HSA if no metastasis on staging sx alone MST ~ 2-4 mths; sx + Doxorubicin MST ~ 4 - 6 mths
  • Metronomic chemotherapy possible option
31
Q

What is thew outcomes of haemangiosarcomas?

A
  • Splenic, intramuscular/subcutaneous and right atrial
    appendage HSA have a poor px = MST less than 6 months in most studies
  • Intramuscular HSA in cats can be less aggressive
  • Dermal HSA can have an excellent outcome = MST of around 1000 days
32
Q

What is histiocytic sarcomas? Where does it affect?

A
  • Highly metastatic sarcoma
  • Arising from histiocytes – professional antigen presenting cells of the immune system
  • Can affect lung, spleen, liver, bone, brain and joint
33
Q

Tx of histiocytic sarcomas?

A
  • Best outcomes are achieved with multi-modal therapy =
  • Surgery, radiation and lomustine/anthracycline chemotherapy
  • Dogs with gross metastasis have quite short survival = MST circa 4 – 5 months
  • Dogs with complete response to therapy or no metastasis at diagnosis who have chemotherapy live much longer = MST circa 500 days
  • Dogs with solitary periarticular histiocytic sarcoma
  • No metastasis or disseminated disease at staging can have very prolonged survival